MedTrace Logo

Treatment of Asymptomatic Bacteriuria in Pregnancy

NCT02911662 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2018-04-18

No results posted yet for this study

Summary

This is a prospective randomized controlled day comparing the efficacy of three-day antimicrobial treatment of asymptomatic bacteriuria (ASB) in pregnancy to the standard seven-day treatment. Half the patients will receive 3-day treatment and the other half will receive 7 days of antibiotics.

Conditions

  • Bacteriuria (Asymptomatic) in Pregnancy

Interventions

DRUG

Cephalexin

Cephalexin will be prescribed for women with a positive urine culture but no symptoms of urinary tract infection.

DRUG

Nitrofurantoin

Macrobid will be prescribed for women allergic to penicillin with a positive urine culture but no symptoms of urinary tract infection.

Sponsors & Collaborators

  • Trinity Health Michigan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02911662 on ClinicalTrials.gov